Fact check
“HHS recommended placing cannabis in Schedule III after reconsidering its potential for abuse.”
Reasoning
The claim that HHS recommended moving cannabis to Schedule III is corroborated by two secondary reporting articles, each quoting the recommendation. No evidence contradicts this statement.
On confidence: High confidence based on consistent reporting across independent secondary sources.
Important context
The recommendation pertains to the potential for abuse classification and was part of a broader discussion on drug scheduling; it does not indicate final regulatory action.
Evidence
Supporting (2)
- Tier 3 — Secondary reporting35 Years Ago, a Judge Said Marijuana Did Not Belong in Schedule I. HHS Finally Agrees.
Schedule I to Schedule V, the least restrictive category, or deschedule it entirely. The BNDD initially refused even to consider the petition, claiming that it would violate the Single Convention on Narcotic Drugs. Even if that might be…
- Tier 3 — Secondary reportingFederal drug scheduling relies on vague criteria, GAO report finds
"potential for abuse," recommended placing it in Schedule III, which includes prescription drugs such as ketamine, anabolic steroids, and Tylenol with codeine. Last April, Acting Attorney General Todd Blanche issued a final rule that…
Limitations
The evidence consists of secondary reporting articles rather than primary HHS documents, so the exact wording and scope of the recommendation cannot be confirmed directly from the source. No independent origin corroborated this claim, so it cannot be verified and confidence cannot be high.
- Last verified:
- Oct 2, 2026, 4:28 AM CDT
- Pipeline:
- 2.1.0
- Claim type:
- Factual
Where this claim appeared
Hazy Drug Classification Criteria Invite Dubious Bureaucratic JudgmentsReason · Jacob Sullum